Connection
David Pollock to Therapeutic Equivalency
This is a "connection" page, showing publications David Pollock has written about Therapeutic Equivalency.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.017 |
|
|
|
-
Stocks JM, Brantly M, Pollock D, Barker A, Kueppers F, Strange C, Donohue JF, Sandhaus R. Multi-center study: the biochemical efficacy, safety and tolerability of a new alpha1-proteinase inhibitor, Zemaira. COPD. 2006 Mar; 3(1):17-23.
Score: 0.017